Oleanolic Acid Cubic Liquid Crystal Nanoparticle-Based Thermosensitive Gel Attenuates Depression Symptoms in Chronic Unpredictable Mild Stress Rats

Overview

Journal Drug Des Devel Ther

Date 2025 Feb 6

PMID 39911446

Authors

Zhiqi Shi

Qing Wang

Qing Li

Fan Jia

Weifeng Xu

Affiliations

Soon will be listed here.

Abstract

Purpose: Major depressive disorder (MDD) is a global health concern. Studies have demonstrated that oleanolic acid (OA) has a regulatory effect on MDD. However, OA is poorly soluble, has low oral bioavailability, and faces challenges in crossing the blood-brain barrier. In this study, building upon a previous formulation of OA cubic liquid crystal nanoparticles (OA-LCNP), we combined nanoparticles with a thermosensitive gel for nasal administration and investigated the pharmacological effects of OA-LCNP thermosensitive gel (OANG) on depression. This study aimed to evaluate the effects of OANG on depression symptoms in rats.

Methods: OANG was prepared using Poloxamer F127 and F68 as the gel matrix, and the ratios of F127 and F68 were investigated. The pharmacokinetics of OANG was studied in rats, and OA content was determined using liquid chromatography-mass spectrometry (LC-MS). The pharmacological effects of OANG on depression were evaluated in chronic unpredictable mild stress (CUMS) model rats.

Results: The phase transition temperature of the gel was 34°C, and the release of OA from OANG was slow according to the Higuchi kinetic equation. The AUC of brain tissue after nasal OANG administration was 1.21 times that observed after intravenous administration. Additionally, the brain-targeting efficiency and nasal-brain direct transfer were 29.91% and 9.44% higher, respectively, than those observed after intravenous administration, indicating the brain-targeting capability of the OANG delivery system. Network pharmacological analysis revealed that the anti-depressant effects may be linked to neuroactive ligand-receptor interactions, the PPAR signaling pathway, and efferocytosis signaling pathways. Experimental results from CUMS rats showed that the gel significantly affected interleukin (IL)-4, IL-6, acetylcholinesterase, acetylcholine, 5-hydroxytryptamine, and brain-derived neurotrophic factor, and improved depression-like behavior in rats, as measured by sucrose preference, forced swimming, and box shuttle tests.

Conclusion: The OANG nasal drug delivery system has specific brain-targeting properties and exerts anti-depressant effects.

References

Jeong D, Kim Y, Kim H, Ji H, Yoo S, Choi W . Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats. Biopharm Drug Dispos. 2006; 28(2):51-7. DOI: 10.1002/bdd.530. View

Yi L, Li J, Liu Q, Geng D, Zhou Y, Ke X . Antidepressant-like effect of oleanolic acid in mice exposed to the repeated forced swimming test. J Psychopharmacol. 2012; 27(5):459-68. DOI: 10.1177/0269881112467090. View

Song J, Lu C, Leszek J, Zhang J . Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms. Int J Mol Sci. 2021; 22(18). PMC: 8465340. DOI: 10.3390/ijms221810118. View

Molendijk M, Spinhoven P, Polak M, Bus B, Penninx B, Elzinga B . Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). Mol Psychiatry. 2013; 19(7):791-800. DOI: 10.1038/mp.2013.105. View

Borroto-Escuela D, Ambrogini P, Chruscicka B, Lindskog M, Crespo-Ramirez M, Hernandez-Mondragon J . The Role of Central Serotonin Neurons and 5-HT Heteroreceptor Complexes in the Pathophysiology of Depression: A Historical Perspective and Future Prospects. Int J Mol Sci. 2021; 22(4). PMC: 7919680. DOI: 10.3390/ijms22041927. View

Zhong Y, Su C, Wu S, Miao C, Wang B . Nasal delivery of an immunotherapeutic vaccine in thermosensitive hydrogel against allergic asthma. Int Immunopharmacol. 2023; 116:109718. DOI: 10.1016/j.intimp.2023.109718. View

Castellano J, Ramos-Romero S, Perona J . Oleanolic Acid: Extraction, Characterization and Biological Activity. Nutrients. 2022; 14(3). PMC: 8838233. DOI: 10.3390/nu14030623. View

Pardridge W . The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005; 2(1):3-14. PMC: 539316. DOI: 10.1602/neurorx.2.1.3. View

Ding K, Wang F, Wang K, Feng X, Yang M, Han B . Environmental stress during adolescence promotes depression-like behavior and endocrine abnormalities in rats. Behav Brain Res. 2023; 457:114710. DOI: 10.1016/j.bbr.2023.114710. View

10.

Xin C, Xia J, Liu Y, Zhang Y . MicroRNA-202-3p Targets Brain-Derived Neurotrophic Factor and Is Involved in Depression-Like Behaviors. Neuropsychiatr Dis Treat. 2020; 16:1073-1083. PMC: 7186893. DOI: 10.2147/NDT.S241136. View

11.

Neuhauser M, Jockel K . A bootstrap test for the analysis of microarray experiments with a very small number of replications. Appl Bioinformatics. 2006; 5(3):173-9. DOI: 10.2165/00822942-200605030-00005. View

12.

Malhi G, Mann J . Depression. Lancet. 2018; 392(10161):2299-2312. DOI: 10.1016/S0140-6736(18)31948-2. View

13.

Pailla S, Sampathi S, Junnuthula V, Maddukuri S, Dodoala S, Dyawanapelly S . Brain-Targeted Intranasal Delivery of Zotepine Microemulsion: Pharmacokinetics and Pharmacodynamics. Pharmaceutics. 2022; 14(5). PMC: 9145021. DOI: 10.3390/pharmaceutics14050978. View

14.

Ning B, Wang Z, He J, Wu Q, Deng Q, Yang Q . The rapid antidepressant effect of acupuncture on two animal models of depression by inhibiting M1-Ach receptors regulates synaptic plasticity in the prefrontal cortex. Brain Res. 2023; 1822():148609. DOI: 10.1016/j.brainres.2023.148609. View

15.

Naghdi M, Ghovvati M, Rabiee N, Ahmadi S, Abbariki N, Sojdeh S . Magnetic nanocomposites for biomedical applications. Adv Colloid Interface Sci. 2022; 308:102771. DOI: 10.1016/j.cis.2022.102771. View

16.

Sridhar V, Wairkar S, Gaud R, Bajaj A, Meshram P . Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's disease. J Drug Target. 2017; 26(2):150-161. DOI: 10.1080/1061186X.2017.1350858. View

17.

Panos G, Boeckler F . Statistical Analysis in Clinical and Experimental Medical Research: Simplified Guidance for Authors and Reviewers. Drug Des Devel Ther. 2023; 17:1959-1961. PMC: 10328100. DOI: 10.2147/DDDT.S427470. View

18.

Marquele-Oliveira F, Torres E, Barud H, Zoccal K, Faccioli L, Hori J . Physicochemical characterization by AFM, FT-IR and DSC and biological assays of a promising antileishmania delivery system loaded with a natural Brazilian product. J Pharm Biomed Anal. 2016; 123:195-204. DOI: 10.1016/j.jpba.2016.01.045. View

19.

Dong S, Wang S, Zhu J, Mu R, Li C, Geng D . Oleanolic acid decreases SGK1 in the hippocampus in corticosterone-induced mice. Steroids. 2019; 149:108419. DOI: 10.1016/j.steroids.2019.05.011. View

20.

Chen S, Asakawa T, Ding S, Liao L, Zhang L, Shen J . Chaihu-Shugan-San administration ameliorates perimenopausal anxiety and depression in rats. PLoS One. 2013; 8(8):e72428. PMC: 3754981. DOI: 10.1371/journal.pone.0072428. View